{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:34:06Z","timestamp":1766075646032,"version":"3.48.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018362","name":"Morningside Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.127956","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:43:15Z","timestamp":1763023395000},"page":"127956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays"],"prefix":"10.1016","volume":"69","author":[{"given":"Thi Hoai Thu","family":"Do","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Koutsakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.vaccine.2025.127956_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126381","article-title":"Real-world effectiveness of influenza vaccine over a decade during the 2011\u20132021 seasons\u2014implications of vaccine mismatch","volume":"42","author":"Choi","year":"2024","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127956_bb0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2021.12.056","article-title":"Lineage-matched versus mismatched influenza B vaccine effectiveness following seasons of marginal influenza B circulation","volume":"40","author":"Omer","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127956_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiab624","article-title":"Vaccine effectiveness against influenza hospitalization and emergency department visits in 2 a (H3N2) dominant influenza seasons among children< 18 years old\u2014new vaccine surveillance network 2016\u20132017 and 2017\u20132018","volume":"226","author":"Kim","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127956_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14760584.2023.2290691","article-title":"Influenza B virus neuraminidase: a potential target for next-generation vaccines?","volume":"23","author":"Do","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127956_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126994","article-title":"Next-generation seasonal influenza virus vaccines need a neuraminidase component","volume":"54","author":"Krammer","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127956_bb0030","series-title":"First European influenza congress","article-title":"Phase 2 clinical evaluation of an influenza a virus recombinant N2 neuraminidase vaccine","author":"Schiff","year":"2000"},{"year":"2022","series-title":"Moderna Announces First Participants Dosed in Phase 1\/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates","key":"10.1016\/j.vaccine.2025.127956_bb0040"},{"key":"10.1016\/j.vaccine.2025.127956_bb0045","first-page":"54573","article-title":"Measuring influenza neuraminidase inhibition antibody titers by enzyme-linked lectin assay","volume":"115","author":"Gao","year":"2016","journal-title":"Journal of visualized experiments: JoVE"},{"key":"10.1016\/j.vaccine.2025.127956_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","article-title":"An optimized enzyme-linked lectin assay to measure influenza a virus neuraminidase inhibition antibody titers in human sera","volume":"210","author":"Couzens","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2025.127956_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3465-3","article-title":"Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays","volume":"18","author":"Morrison","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127956_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048229","article-title":"Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples","volume":"7","author":"Defang","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127956_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-018-08165-y","article-title":"Cross-lineage protection by human antibodies binding the influenza B hemagglutinin","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127956_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-29416-z","article-title":"Structure-based design of stabilized recombinant influenza neuraminidase tetramers","volume":"13","author":"Ellis","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127956_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01186-24","article-title":"Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase","volume":"98","author":"Do","year":"2024","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127956_bb0080","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza a\/H3N2 viruses: an international collaborative study","volume":"25","author":"Stephenson","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127956_bb0085","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3201\/eid1508.081754","article-title":"Reproducibility of serologic assays for influenza virus a (H5N1)","volume":"15","author":"Stephenson","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127956_bb0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.19-0112","article-title":"Comparison of the use of serum and plasma as matrix specimens in a widely used noncommercial dengue IgG ELISA","volume":"101","author":"Deza-Cruz","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127956_bb0095","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.vaccine.2020.01.088","article-title":"Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement","volume":"38","author":"Sicca","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127956_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2012.10.065","article-title":"Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines","volume":"31","author":"Couch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127956_bb0105","series-title":"Open forum infectious diseases","article-title":"Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010\u20132011 trivalent inactivated influenza vaccination in healthcare personnel","author":"Laguio-Vila","year":"2015"},{"year":"2007","series-title":"The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes","author":"Banfi","key":"10.1016\/j.vaccine.2025.127956_bb0110"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127956_bb0115","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/j.1538-7836.2007.02710.x","article-title":"Citrate anticoagulation and the dynamics of thrombin generation","volume":"5","author":"Mann","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127956_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2265.2006.02439.x","article-title":"Unusual results from immunoassays and the role of the clinical endocrinologist","volume":"64","author":"Jones","year":"2006","journal-title":"Clinical Endocrinology-Oxford"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:28:37Z","timestamp":1766075317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2501254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"alternative-id":["S0264410X2501254X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127956","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127956"}}